Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
18-Mar-2014A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2 '-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancerGlasspool, RM; Brown, R; Gore, ME; Rustin, GJS; McNeish, IA, et al
30-Mar-2017Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortiumGoranova, T; Ennis, D; Piskorz, AM; Macintyre, G; Lewsley, LA, et al
23-Sep-2016Platinum-based chemotherapy induces methylation changes in blood DNA associated with overall survival in ovarian cancer patientsFlanagan, JM; Wilson, A; Koo, C; Masrour, N; Gallon, J, et al
20-May-2015Homologous recombination (HR) deficiency, tumor BRCA1/2 mutations (tmBRCA) and association with response and outcome following platinum monotherapy in high grade serous ovarian cancer (HGSOC).Brown, R; Timms, K; Paul, J; Hughes, E; El-Bahrawy, M, et al
9-Aug-2017Copy-number signatures and mutational processes in ovarian carcinomaMacintyre, G; Goranova, T; De Silva, D; Ennis, D; Piskorz, A, et al
13-Aug-2018Copy-number signatures and mutational processes in ovarian carcinomaMacintyre, G; Goranova, TE; De Silva, D; Ennis, D; Piskorz, AM, et al
1-Jul-2018Biomarker assessment of HR deficiency, tumor BRCA1/2 mutations and CCNE1 copy number in ovarian cancer: associations with clinical outcome following platinum monotherapyStronach, EA; Paul, J; Timms, KM; Hughes, E; Brown, K, et al